Stellungnahme zum 2. Entwurf „Commission Delegated Regulation (EU) 2019/6 establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans” mit Annex
Summary
Germanwatch, Greenpeace, and other partners argue that the proposed EU criteria for reserving antimicrobials for human use are flawed because they allow for the continued use of reserve antibiotics in livestock if deemed 'essential' for animal health. They contend this undermines Regulation (EU) 2019/6, which aims to end the routine use of antimicrobials in farming to combat antimicrobial resistance (AMR). The signatories demand that the EU adopt the WHO's 'Critically Important Antimicrobials Highest Priority' list and its criteria to ensure these drugs are reserved exclusively for human medicine.
Key insights
- The signatories argue that the second draft of the delegated regulation contradicts the goal of reserving specific antibiotics for human treatment. Specifically, they claim that 'Criterion 3'—which considers whether an antimicrobial is 'not essential to preserve animal health'—effectively prioritizes animal health over human health, regardless of poor breeding or housing conditions.
- The document asserts that the proposed language regarding 'animal welfare' in Section C of the Annex is imprecise and could serve as a loophole to justify the widespread use of reserve antibiotics in livestock, as 'animal welfare' is not defined and does not constitute a bacterial infection requiring antibiotics.
- The authors highlight a discrepancy between current practices and EMA recommendations, noting that Colistin use in German poultry farming (7.9 mg per kg of animal weight per year) significantly exceeds the EMA's maximum limit of 5 mg intended to prevent AMR.
- The signatories demand that the EU exclusively reserve reserve antibiotics for humans based on the WHO list for 'Critically Important Antimicrobials Highest Priority' and adopt the WHO's transparent criteria for determining which antibiotics should not be authorized for food-producing animals.
Cite the original document
- APA
- Germanwatch (2020). Stellungnahme zum 2. Entwurf „Commission Delegated Regulation (EU) 2019/6 establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans” mit Annex. https://www.germanwatch.org/sites/default/files/2020%2010%2015%20Gemeins.Stellungn.%20Entwurf%20del.%20Rechtsakt%20zu%20EU%202019_6.pdf
- Chicago
- Germanwatch. Stellungnahme zum 2. Entwurf „Commission Delegated Regulation (EU) 2019/6 establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans” mit Annex. 2020. https://www.germanwatch.org/sites/default/files/2020%2010%2015%20Gemeins.Stellungn.%20Entwurf%20del.%20Rechtsakt%20zu%20EU%202019_6.pdf.
- Wikipedia
- {{cite press release |author=Germanwatch |title=Stellungnahme zum 2. Entwurf „Commission Delegated Regulation (EU) 2019/6 establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans” mit Annex |date=15 October 2020 |url=https://www.germanwatch.org/sites/default/files/2020%2010%2015%20Gemeins.Stellungn.%20Entwurf%20del.%20Rechtsakt%20zu%20EU%202019_6.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document gerwat-000979)}}
- BibTeX
- @misc{germanwatch2020stellungnahme, author = {{Germanwatch}}, title = {{Stellungnahme zum 2. Entwurf „Commission Delegated Regulation (EU) 2019/6 establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans” mit Annex}}, publisher = {Germanwatch}, year = {2020}, month = oct, url = {https://www.germanwatch.org/sites/default/files/2020%2010%2015%20Gemeins.Stellungn.%20Entwurf%20del.%20Rechtsakt%20zu%20EU%202019_6.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document gerwat-000979} }
Full text
Collected · Record updated